JP2023541400A5 - - Google Patents
Info
- Publication number
- JP2023541400A5 JP2023541400A5 JP2023516171A JP2023516171A JP2023541400A5 JP 2023541400 A5 JP2023541400 A5 JP 2023541400A5 JP 2023516171 A JP2023516171 A JP 2023516171A JP 2023516171 A JP2023516171 A JP 2023516171A JP 2023541400 A5 JP2023541400 A5 JP 2023541400A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- fusion protein
- acid sequence
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025123695A JP2025183960A (ja) | 2020-09-11 | 2025-07-24 | Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063077089P | 2020-09-11 | 2020-09-11 | |
| US63/077,089 | 2020-09-11 | ||
| US202163146840P | 2021-02-08 | 2021-02-08 | |
| US63/146,840 | 2021-02-08 | ||
| PCT/US2021/049853 WO2022056254A2 (en) | 2020-09-11 | 2021-09-10 | Dna modifying enzymes and active fragments and variants thereof and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025123695A Division JP2025183960A (ja) | 2020-09-11 | 2025-07-24 | Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023541400A JP2023541400A (ja) | 2023-10-02 |
| JP2023541400A5 true JP2023541400A5 (cg-RX-API-DMAC7.html) | 2024-09-19 |
| JP7719172B2 JP7719172B2 (ja) | 2025-08-05 |
Family
ID=78087537
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023516171A Active JP7719172B2 (ja) | 2020-09-11 | 2021-09-10 | Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法 |
| JP2025123695A Pending JP2025183960A (ja) | 2020-09-11 | 2025-07-24 | Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025123695A Pending JP2025183960A (ja) | 2020-09-11 | 2025-07-24 | Dna修飾酵素並びにその活性断片及びバリアント並びにその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (9) | US12398384B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4211235A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7719172B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230084505A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021339805A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3173886A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL301139A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023002848A (cg-RX-API-DMAC7.html) |
| TW (2) | TWI910226B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022056254A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202304237B (cg-RX-API-DMAC7.html) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019217942A1 (en) | 2018-05-11 | 2019-11-14 | Beam Therapeutics Inc. | Methods of substituting pathogenic amino acids using programmable base editor systems |
| KR20210055733A (ko) | 2018-09-07 | 2021-05-17 | 빔 테라퓨틱스, 인크. | 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법 |
| EP3850088A4 (en) | 2018-09-07 | 2023-07-19 | Beam Therapeutics, Inc. | Compositions and methods for improving base editing |
| JP7646552B2 (ja) | 2019-01-31 | 2025-03-17 | ビーム セラピューティクス インク. | 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ |
| US12600971B2 (en) | 2019-02-13 | 2026-04-14 | Beam Therapeutics Inc. | Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence |
| WO2020168135A1 (en) | 2019-02-13 | 2020-08-20 | Beam Therapeutics Inc. | Compositions and methods for treating alpha-1 antitrypsin deficiency |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US12594301B2 (en) | 2019-09-27 | 2026-04-07 | Beam Therapeutics Inc. | Compositions and methods for treatment of liquid cancers |
| AU2021347359A1 (en) | 2020-09-25 | 2023-05-18 | Beam Therapeutics Inc. | Fratricide resistant modified immune cells and methods of using the same |
| CA3173953A1 (en) | 2021-06-11 | 2023-12-10 | Tyson D. BOWEN | Rna polymerase iii promoters and methods of use |
| CN114634923B (zh) * | 2022-04-07 | 2024-02-23 | 尧唐(上海)生物科技有限公司 | 腺苷脱氨酶、碱基编辑器融合蛋白、碱基编辑器系统及用途 |
| CN114686456B (zh) | 2022-05-10 | 2023-02-17 | 中山大学 | 基于双分子脱氨酶互补的碱基编辑系统及其应用 |
| AU2023323547A1 (en) | 2022-08-12 | 2025-03-20 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
| WO2024042489A1 (en) | 2022-08-25 | 2024-02-29 | LifeEDIT Therapeutics, Inc. | Chemical modification of guide rnas with locked nucleic acid for rna guided nuclease-mediated gene editing |
| IL320573A (en) | 2022-11-04 | 2025-07-01 | Life Edit Therapeutics Inc | Developed adenine deaminases and RNA-guided nuclease fusion proteins with internal insertion sites and methods of use |
| WO2024127370A1 (en) | 2022-12-16 | 2024-06-20 | LifeEDIT Therapeutics, Inc. | Guide rnas that target trac gene and methods of use |
| WO2024127369A1 (en) | 2022-12-16 | 2024-06-20 | LifeEDIT Therapeutics, Inc. | Guide rnas that target foxp3 gene and methods of use |
| WO2024178397A2 (en) | 2023-02-24 | 2024-08-29 | Elevatebio Technologies, Inc. | Modified immune effector cells and methods of use |
| CN117965505A (zh) * | 2023-06-28 | 2024-05-03 | 微光基因(苏州)有限公司 | 工程化的腺苷脱氨酶及碱基编辑器 |
| EP4750890A2 (en) | 2023-07-27 | 2026-06-03 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
| CN122422501A (zh) | 2023-10-18 | 2026-07-17 | 生命编辑治疗股份有限公司 | Rna引导的核酸酶及其活性片段和变体以及使用方法 |
| CN122161928A (zh) | 2023-10-25 | 2026-06-05 | 上海尧唐生物科技股份有限公司 | 一种脱氨酶、包含其的碱基编辑器及其应用 |
| WO2025122725A1 (en) * | 2023-12-06 | 2025-06-12 | The Broad Institute, Inc. | Methods and compositions for base editing of tpp1 in the treatment of batten disease |
| CN117511912B (zh) * | 2023-12-22 | 2024-03-29 | 辉大(上海)生物科技有限公司 | IscB多肽、包含其的系统及其用途 |
| WO2025174908A1 (en) | 2024-02-12 | 2025-08-21 | Life Edit Therapeutics, Inc. | Novel rna-guided nucleases and proteins for polymerase editing |
| WO2025206105A1 (ja) * | 2024-03-29 | 2025-10-02 | 株式会社Frest | 標的アデノシンに対する部位特異的編集を誘導するオリゴヌクレオチド |
| TW202617985A (zh) | 2024-06-25 | 2026-05-01 | 美商生命編輯治療學公司 | 新穎反轉錄酶及其用途 |
| WO2026143185A1 (en) | 2024-12-23 | 2026-07-02 | Ensoma Aps | Engineered rna-guided dna-binding polypeptides |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217344A (en) | 1976-06-23 | 1980-08-12 | L'oreal | Compositions containing aqueous dispersions of lipid spheres |
| US4196265A (en) | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4186183A (en) | 1978-03-29 | 1980-01-29 | The United States Of America As Represented By The Secretary Of The Army | Liposome carriers in chemotherapy of leishmaniasis |
| US4261975A (en) | 1979-09-19 | 1981-04-14 | Merck & Co., Inc. | Viral liposome particle |
| US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5380831A (en) | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
| US4946787A (en) | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5049386A (en) | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5569597A (en) | 1985-05-13 | 1996-10-29 | Ciba Geigy Corp. | Methods of inserting viral DNA into plant material |
| US4774085A (en) | 1985-07-09 | 1988-09-27 | 501 Board of Regents, Univ. of Texas | Pharmaceutical administration systems containing a mixture of immunomodulators |
| US4853331A (en) | 1985-08-16 | 1989-08-01 | Mycogen Corporation | Cloning and expression of Bacillus thuringiensis toxin gene toxic to beetles of the order Coleoptera |
| US5268463A (en) | 1986-11-11 | 1993-12-07 | Jefferson Richard A | Plant promoter α-glucuronidase gene construct |
| US5608142A (en) | 1986-12-03 | 1997-03-04 | Agracetus, Inc. | Insecticidal cotton plants |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5039523A (en) | 1988-10-27 | 1991-08-13 | Mycogen Corporation | Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| KR920701453A (ko) | 1989-03-17 | 1992-08-11 | 미리엄 디. 멕코나헤이 | 유전자발현의 외부조절 |
| ES2187497T3 (es) | 1990-04-12 | 2003-06-16 | Syngenta Participations Ag | Promotores preferentemente en tejidos. |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| AU7979491A (en) | 1990-05-03 | 1991-11-27 | Vical, Inc. | Intracellular delivery of biologically active substances by means of self-assembling lipid complexes |
| US5498830A (en) | 1990-06-18 | 1996-03-12 | Monsanto Company | Decreased oil content in plant seeds |
| CA2051562C (en) | 1990-10-12 | 2003-12-02 | Jewel M. Payne | Bacillus thuringiensis isolates active against dipteran pests |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5399680A (en) | 1991-05-22 | 1995-03-21 | The Salk Institute For Biological Studies | Rice chitinase promoter |
| JPH06510187A (ja) | 1991-08-27 | 1994-11-17 | ノバルティス アクチエンゲゼルシャフト | 同翅類昆虫に対する殺虫性質を有したタンパク質及び植物保護におけるそれらの用法 |
| TW261517B (cg-RX-API-DMAC7.html) | 1991-11-29 | 1995-11-01 | Mitsubishi Shozi Kk | |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| US5789156A (en) | 1993-06-14 | 1998-08-04 | Basf Ag | Tetracycline-regulated transcriptional inhibitors |
| US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5608144A (en) | 1994-08-12 | 1997-03-04 | Dna Plant Technology Corp. | Plant group 2 promoters and uses thereof |
| US5659026A (en) | 1995-03-24 | 1997-08-19 | Pioneer Hi-Bred International | ALS3 promoter |
| US6072050A (en) | 1996-06-11 | 2000-06-06 | Pioneer Hi-Bred International, Inc. | Synthetic promoters |
| ES2270227T3 (es) | 1998-02-26 | 2007-04-01 | Pioneer Hi-Bred International, Inc. | Promotor met-1 del maiz. |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| CN1360632A (zh) | 1999-05-04 | 2002-07-24 | 孟山都技术有限公司 | 鞘翅目毒性多肽组合物和抗虫转基因植物 |
| BR0014516A (pt) | 1999-09-15 | 2002-07-02 | Monsanto Technology Llc | Composições e métodos de uso de delta-endotoxina do bacilo thuringiensis ativo de lepidopteran |
| US20050183161A1 (en) | 2003-10-14 | 2005-08-18 | Athenix Corporation | AXMI-010, a delta-endotoxin gene and methods for its use |
| US7629504B2 (en) | 2003-12-22 | 2009-12-08 | Pioneer Hi-Bred International, Inc. | Bacillus thuringiensis cry9 nucleic acids |
| ES2397118T3 (es) | 2006-06-14 | 2013-03-04 | Athenix Corporation | AXMI-031, AXMI-039 ,AXMI-040 y AXMI-049, una familia de genes de endotoxina delta y métodos para su uso |
| CN102648281B (zh) | 2009-07-02 | 2017-04-05 | 阿森尼克斯公司 | Axmi‑205杀虫基因和它的使用方法 |
| US8586832B2 (en) | 2009-12-21 | 2013-11-19 | Pioneer Hi Bred International Inc | Bacillus thuringiensis gene with Lepidopteran activity |
| CN103154247A (zh) | 2010-08-19 | 2013-06-12 | 先锋国际良种公司 | 对鳞翅目昆虫具有活性的新苏云金杆菌基因 |
| US9405700B2 (en) | 2010-11-04 | 2016-08-02 | Sonics, Inc. | Methods and apparatus for virtualization in an integrated circuit |
| ES2728782T3 (es) | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| US10450584B2 (en) | 2014-08-28 | 2019-10-22 | North Carolina State University | Cas9 proteins and guiding features for DNA targeting and genome editing |
| AU2016226077B2 (en) | 2015-03-03 | 2021-12-23 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases with altered PAM specificity |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| AU2019282149B2 (en) | 2018-06-05 | 2025-08-21 | Life Edit Therapeutics, Inc. | RNA-guided nucleases and active fragments and variants thereof and methods of use |
| CA3125175A1 (en) * | 2018-12-27 | 2020-07-02 | LifeEDIT Therapeutics, Inc. | Polypeptides useful for gene editing and methods of use |
| CN113631704A (zh) * | 2018-12-27 | 2021-11-09 | 生命编辑制药股份有限公司 | 可用于基因编辑的多肽及使用方法 |
| WO2020181195A1 (en) | 2019-03-06 | 2020-09-10 | The Broad Institute, Inc. | T:a to a:t base editing through adenine excision |
| CN118813654A (zh) | 2019-08-12 | 2024-10-22 | 生命编辑制药股份有限公司 | Rna指导的核酸酶及其活性片段及变体以及使用方法 |
-
2021
- 2021-09-10 EP EP21790678.3A patent/EP4211235A2/en active Pending
- 2021-09-10 IL IL301139A patent/IL301139A/en unknown
- 2021-09-10 JP JP2023516171A patent/JP7719172B2/ja active Active
- 2021-09-10 WO PCT/US2021/049853 patent/WO2022056254A2/en not_active Ceased
- 2021-09-10 AU AU2021339805A patent/AU2021339805A1/en active Pending
- 2021-09-10 TW TW110133778A patent/TWI910226B/zh active
- 2021-09-10 MX MX2023002848A patent/MX2023002848A/es unknown
- 2021-09-10 TW TW114146258A patent/TW202617984A/zh unknown
- 2021-09-10 KR KR1020237012126A patent/KR20230084505A/ko active Pending
- 2021-09-10 CA CA3173886A patent/CA3173886A1/en active Pending
-
2022
- 2022-06-28 US US17/851,880 patent/US12398384B2/en active Active
- 2022-09-01 US US17/929,162 patent/US11981940B2/en active Active
-
2023
- 2023-04-06 ZA ZA2023/04237A patent/ZA202304237B/en unknown
-
2024
- 2024-04-01 US US18/623,704 patent/US12188061B2/en active Active
- 2024-04-05 US US18/628,400 patent/US20240344043A1/en not_active Abandoned
- 2024-04-05 US US18/627,839 patent/US12188062B2/en active Active
- 2024-04-10 US US18/631,568 patent/US12252718B2/en active Active
- 2024-11-13 US US18/946,402 patent/US20250066753A1/en active Pending
- 2024-11-21 US US18/955,480 patent/US20250084393A1/en active Pending
-
2025
- 2025-02-17 US US19/055,281 patent/US20250250554A1/en active Pending
- 2025-07-24 JP JP2025123695A patent/JP2025183960A/ja active Pending